Apogee Therapeutics, Inc. (NASDAQ:APGE) showed up in the 13F filings of 203 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,097,968 | 40.88% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 1,308,576 | 18.92% | $0.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 1,000,000 | 0.00% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 22,884 | 0.48% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 4,287,002 | 297,501.87% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -874,169 | -86.78% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 612,193 | 27.26% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 674 | 0.00% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 0 | 61,500 | 5.24% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 978,662 | 72.39% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | -398,514 | -26.19% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 25,202 | 1.17% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 175,361 | 21.93% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 1,576,626 | 324.42% | $0.00 |
| Remedium Capital Partners, LLC | 31 Dec, 2025 | 0 | 583,591 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 34,638 | 2.09% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | -863,678 | -60.03% | $0.00 |